Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy

Early therapies to prevent severe COVID-19 have an unclear impact on patients with hematological malignancies. The aim of this study was to assess their efficacy in this group of high-risk patients with COVID-19 in preventing hospitalizations and reducing the SARS-CoV-2 shedding. This was a single-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Colaneri, Marta, Pieri, Teresa Chiara, Roda, Silvia, Ricciardi, Alessandra, Gotti, Manuel, Ferrari, Jacqueline, Arcaini, Luca, Rattotti, Sara, Piralla, Antonio, Giardina, Federica, Ferrari, Guglielmo, Sacchi, Paolo, Zuccaro, Valentina, Baldanti, Fausto, Bruno, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782181/
https://www.ncbi.nlm.nih.gov/pubmed/36556068
http://dx.doi.org/10.3390/jcm11247452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782181/
https://www.ncbi.nlm.nih.gov/pubmed/36556068
http://dx.doi.org/10.3390/jcm11247452

Ejemplares similares